Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in multiple publications regarding mHealth regulations and industry standards across state lines.
Following is an excerpt from FierceHealthcare, “mHealth Settlement Raises Concerns About Future State-Based Enforcement,” by Evan Sweeney.
If states decide to pursue potentially misleading advertising claims made by digital health apps, it could create confusion within the industry, Bradley Merrill Thompson, an attorney with Epstein Becker Green in the District of Columbia, told FierceHealthcare.
“If all 50 states were to get active in this, it would be highly likely that each state would look at claims a little bit differently,” he said in an email. “As a result, in effect, developers would have to comply with whatever the most demanding state requires.”
Related reading:
POLITICO Morning eHealth, “Repeal-And-Replace Cliffhanger,” by Darius Tahir.
Health Data Management, “New York Attorney General Puts mHealth App Developers on Notice,” by Greg Slabodkin.
